46.0
Marker Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
16.6
FY23:
17.1
FY24:
22.0
FY25:
19.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.2
FY22:
17.8
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
68.1
FY22:
34.4
FY23:
17.1
FY24:
22.0
FY25:
19.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.9
FY22:
7.78
FY23:
3.07
FY24:
3.46
FY25:
2.27
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.2
FY22:
7.04
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
44.0
FY22:
19.6
FY23:
14.1
FY24:
18.6
FY25:
16.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
68.1
FY22:
34.4
FY23:
17.1
FY24:
22.0
FY25:
19.1
All amounts in millions USD